Macroalgal Bloom Biomass as a Source of Bioactive Compounds and Antimicrobial Peptides
spp., among others. The indicated species are known for their diverse pharmacological properties, including antimicrobial, antioxidant, and anti-inflammatory effects. Specialised bioinformatic tools were employed to assess the potential of identified macroalgae as a source of antimicrobial peptides (AMPs). For selected macroalgal species, in silico screening of publicly available databases was performed to identify previously reported and characterised AMPs associated with these species. This in silico approach presents a promising strategy for discovering novel antimicrobial agents with potential activity, especially against drug-resistant bacteria. Finally, applying proteomics methodologies for in silico evaluation of the selected algal species advances modern technologies for the sustainable use of natural resources.
Authors
- Carol Thornber (ORCID: https://orcid.org/0000-0003-0034-1035)
- Nedeljka Rosić (ORCID: https://orcid.org/0000-0002-2598-7046)
- Isidora Skrlin
Institutions
- The University of Queensland (AU)
- University of Massachusetts Boston (US)
- Southern Cross University (AU)
Publication Details
- Journal
- Marine Drugs
- Published
- 2026-04-15
- DOI
- https://doi.org/10.3390/md24040136
- Primary Topic
- Seaweed-derived Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Faculty of Health, Southern Cross University
- Southern Cross University